These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9723432)

  • 21. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 22. Indications for mycofenolate mofetil therapy after liver transplantation.
    Platz KP; Mueller AR; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
    [No Abstract]   [Full Text] [Related]  

  • 23. Basiliximab reduces acute liver allograft rejection in pediatric patients.
    Strassburg A; Pfister ED; Arning A; Nashan B; Ehrich JH; Melter M
    Transplant Proc; 2002 Sep; 34(6):2374-5. PubMed ID: 12270443
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation.
    Scholler G; Rose M; Neuhaus R; Neuhaus P; Klapp BF
    Transplant Proc; 1997 Aug; 29(5):2491-3. PubMed ID: 9270822
    [No Abstract]   [Full Text] [Related]  

  • 25. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
    Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM; Lohmann R; Guckelberger O; Müller AR; Raakow R; Nüssler NC; Klupp J; Pfitzmann R; Jonas S; Settmacher U; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract]   [Full Text] [Related]  

  • 30. Noncompliance after pediatric liver transplantation.
    Molmenti E; Mazariegos G; Bueno J; Cacciarelli T; Alasio T; Khanna A; Kosmach B; Jain A; Fung J; Reyes J
    Transplant Proc; 1999; 31(1-2):408. PubMed ID: 10083164
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin.
    Prescrire Int; 1998 Aug; 7(36):108-9. PubMed ID: 10342948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of immunosuppression on patient outcome after liver transplantation.
    Mueller AR; Platz KP; Willimski C; Berg T; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1495-6. PubMed ID: 9636608
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract]   [Full Text] [Related]  

  • 34. Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan.
    Hung CM; Jeng LB; Yeh CN; Hsieh CH; Lee WC; Chen MF
    Transplant Proc; 1998 Nov; 30(7):3589. PubMed ID: 9838572
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Bruijn JA; van der Woude FJ
    Lancet; 2002 Sep; 360(9335):800; author reply 800-1. PubMed ID: 12241846
    [No Abstract]   [Full Text] [Related]  

  • 37. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 38. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
    Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
    Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL; Metselaar HJ
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.